| 标题 |
Innovative research for the pathogenesis of myasthenia gravis in traditional Chinese medicine
重症肌无力中医病机创新研究
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | INTERVENTION: 1:tonify spleen qi;2:tonify spleen qi and rise yang;3:tonify spleen and kidney;4:tonify spleen and kidney, rise yang; CONDITION: myasthenia gravis PRIMARY OUTCOME: MGC score;QMG score; SECONDARY OUTCOME: Incidence of related events: mortality, myasthenia crisis, thymectomy;Evaluation of curative effect of TCM syndrome;Dosage of glucocorticoid and immunosuppressive drugs;Quality of life evaluation: MG‐ADL scale, MG‐PRO scale evaluation; INCLUSION CRITERIA: 1. Patients with ophthalmic muscle, medulla oblongata or systemic mg18‐65 years old and with onset of systemic symptoms or systemic diseases confirmed by neurophysiological tests for no more than 12 months; 2. The diagnosis of Mg should be determined according to the following methods (refer to the Chinese myasthenia gravis diagnosis and treatment guidelines in 2015): |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)